Searchable abstracts of presentations at key conferences in endocrinology

ea0011p484 | Endocrine tumours and neoplasia | ECE2006

Development of a non-isotopic immunoassay for the measurement of aldosterone in saliva

Manolopoulou J , Bidlingmaier M

The purpose of our study was to establish an assay for the measurement of aldosterone in saliva which utilises a simple, non-invasive sampling technique on an out-patient basis. For this we have developed a non-isotopic, time-resolved fluorescence immunoassay. The assay only requires a volume of 100 μl for each duplicate value obtained and involves an overnight incubation after extraction of samples. Cross-reactivity with potentially interfering steroids is below 0.01%. T...

ea0029p288 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Plasma aldosterone to plasma renin ratio on an automated analyzer using two novel chemiluminescence immunoassays

Manolopoulou J. , Bennett A. , Grimminger P. , Fischer E. , Pallauf A. , Reincke M. , Diederich S. , Bidlingmaier M.

Background: Screening for primary aldosteronism (PA) using the aldosterone to renin ratio (ARR) is recommended by clinical practice guidelines in patient groups with a high prevalence as the disease is reported by several authors in more than 10% of essential hypertensives (EH).Methods: Plasma aldosterone concentration (PAC) and direct renin (DR) were measured using two novel automated chemiluminescence assays (IDS-iSYS; Boldon, UK) and compared to the S...